sulin growth factor and Wnt/β-catenin, RANK ligand), and low prevalence of tumor-infiltrating lymphocytes 21 - 23 . The unique biologic features of BCP and the more frequent delay in diagnosis might explain the poor prognosis reported by some authors, even if the immediate postpartum period showed a clear trend toward inferior outcomes compared with outcomes during pregnancy or in women with non-pregnancy-related breast cancer 24 .
← all excerpts
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.
1
—
—